(Reuters) – AstraZeneca Plc said on Thursday it had received the first agreements to supply at least 400 million doses of the COVID-19 vaccine it is developing with the University of Oxford.
The British drugmaker said it has a total capacity sourced for one billion doses through 2020 and into 2021, and continues to increase capacity further.
(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Shounak Dasgupta)
